Terry Day to Aged, 80 and over
This is a "connection" page, showing publications Terry Day has written about Aged, 80 and over.
Connection Strength
1.157
-
Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
Score: 0.080
-
Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018 09; 40(9):1967-1976.
Score: 0.080
-
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History. JAMA Oncol. 2018 Feb 01; 4(2):248-249.
Score: 0.079
-
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
Score: 0.078
-
Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
Score: 0.077
-
Double paddle ulnar perforator free flap in reconstruction of through-and-through and fistulous defects of the head and neck. Laryngoscope. 2017 06; 127(6):1302-1305.
Score: 0.073
-
Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):544-50.
Score: 0.070
-
Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
Score: 0.070
-
Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region. Oral Oncol. 2016 Jan; 52:24-9.
Score: 0.067
-
Predictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients. Otolaryngol Head Neck Surg. 2016 Jan; 154(1):121-30.
Score: 0.067
-
Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
Score: 0.061
-
A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
Score: 0.060
-
Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
Score: 0.036
-
The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
Score: 0.034
-
Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
Score: 0.026
-
Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
Score: 0.023
-
Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
Score: 0.021
-
Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
Score: 0.021
-
Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017 11 01; 143(11):1092-1097.
Score: 0.019
-
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
Score: 0.019
-
Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
Score: 0.019
-
Thyroid disease and compressive symptoms. Laryngoscope. 2012 Jan; 122(1):13-6.
Score: 0.013
-
Neural outcomes after plasma knife dissection: a pathologic study and clinical correlation. Head Neck. 2010 Oct; 32(10):1321-7.
Score: 0.012
-
Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
Score: 0.012
-
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
Score: 0.011
-
Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation. Ann Otol Rhinol Laryngol. 2009 Aug; 118(8):546-51.
Score: 0.011
-
Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
Score: 0.009
-
Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
Score: 0.009